Global Hepatitis Diagnostic Test Market Size (2024 - 2029)

Hepatitis Diagnostic Test Market Analysis

The Global Hepatitis Diagnostic Test Market size is estimated at USD 4.48 billion in 2024, and is expected to reach USD 5.91 billion by 2029, growing at a CAGR of 5.67% during the forecast period (2024-2029).

The impact of COVID-19 in its initial phase was adverse owing to cancellations of diagnostic procedures worldwide. For instance, a research article published in the Journal of Hepatology in July 2022 stated that the COVID-19 pandemic hampered HBV and HCV overall services. The survey was conducted across 32 European and 12 non-European centers dealing with hepatitis B and C services. Chronic HBV consultations decreased by 30%, new referrals by 39%, HBsAg testing was reduced by 35%, and HBV DNA testing was reduced by 29%. HCV during the same time, the overall reductions were 41% for consultations, 49% for new referrals, 12% for HCV RNA detection, and 52% for new HCV antiviral treatments. However, the market gained traction as treatment, diagnostic procedures, and awareness campaigns resumed in the latter phase of the pandemic. For instance, in 2021, World Hepatitis Day was celebrated with the theme "Hepatitis Can'tWait," wherein the event emphasized the need for all countries to work together to eliminate viral hepatitis by 2030. This worldwide initiative by the WHO is anticipated to propel the hepatitis diagnostic test, which is ultimately projected to boost market growth during the forecast period.

The significant factors for the growth of the market include the growing burden of hepatitis, the introduction of molecular diagnostics for the diagnosis of hepatitis, and increasing awareness regarding the disease. For instance, according to the WHO's June 2022 report, an estimated 58 million people suffer from chronic hepatitis C virus infection worldwide, with about 1.5 million new cases occurring annually. There are an estimated 3.2 million adolescents and children with chronic hepatitis C infection. Such a high burden of the disease is anticipated to boost the market's growth. Moreover, awareness campaigns are conducted worldwide to educate people about the treatment and diagnosis of hepatitis. For instance, every year, the World Health Organization organizes a campaign named "World Hepatitis Day" to raise awareness and understanding of viral hepatitis. The WHO is focusing on the theme "Bringing hepatitis care closer to you" for World Hepatitis Day 2022 and has appealed for simplified service delivery of viral hepatitis services to bring care closer to communities. As early diagnosis helps improve the treatment of the disease, these awareness initiatives are projected to boost the demand for hepatitis diagnostics worldwide and augment the market's growth.

Additionally, the advancements in technology and increasing product approvals, along with partnerships and acquisitions by key players, are aiding the market's growth. For instance, in October 2021, Transasia Bio-Medicals, a diagnostic company based in India, launched a high-sensitivity ErbaLisa HCV Gen 4 Ag+Ab testing kit for the hepatitis C virus in India. Based on the latest method, the testing kit is one of India's first indigenously developed 4th generation ELISA kits and has been evaluated by the National Institute of Biologicals (NIB). Such technological advancements are predicted to boost the hepatitis diagnostic test demand and enhance market growth further.

Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the forecast period. However, restricted facilities or services for hepatitis testing and limited access to reliable and low-cost HBV and HCV diagnostics are likely to impede the market's growth.

Hepatitis Diagnostic Test Industry Segmentation

As per the scope of the report, the term hepatitis broadly means inflammation of the liver. Heavy alcohol use, some medications, toxins, and certain medical conditions can cause hepatitis. However, hepatitis is often caused due to viral infection. The most common types of viral hepatitis are hepatitis A, hepatitis B, and hepatitis C. The Hepatitis Diagnostic Test Market is segmented by Test Type, (Blood Tests (Liver Function Tests, Immunoassays and Nucleic Acid Tests), Imaging Tests, and Liver Biopsy) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.